After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
APGE belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Apogee Therapeutics Inc is $2.28B. A total of 0.88 million shares were traded on the day, compared to an average of 879.44K shares.
In the most recent transaction, Dambkowski Carl sold 10,090 shares of APGE for 45.09 per share on Jul 02 ’25. After the transaction, the Chief Medical Officer now owns 238,998 company shares. In a previous transaction on Jul 02 ’25, CARL DAMBKOWSKI bought 22,345 shares at 44.26 per share.
Among the insiders who sold shares, Dambkowski Carl disposed of 2,725 shares on Jun 04 ’25 at a per-share price of $36.96. This resulted in the Chief Medical Officer holding 241,723 shares of APGE after the transaction. In another insider transaction, Dambkowski Carl sold 2,725 shares at $35.75 per share on May 07 ’25. Company shares held by the Chief Medical Officer now total 244,448.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, APGE has a high of $63.50 and a low of $26.20.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for APGE is Buy with a score of 5.00.
